The French drugs group Sanofi-Synthelabo was expected to launch its formal public bid for French-German rival Aventis yesterday, while leaving the closing date for the offer open for now.
Aventis shareholders may either sell their stock for 60.43 euros per share, or exchange six Aventis shares for five of Sanofi plus 69 euros (US$54 dollars) in cash.
The offer values Aventis at 48 billion euros (US$61 billion).
Sanofi will only go ahead with the hostile takeover bid if it is able to buy at least half of the total 802 million Aventis shares.
The offer's closing date depends on a decision by the US Federal Trade Commission (FTC) and on the outcome of current legal action in Paris.
Aventis is contesting the offer before the Paris court of appeal, which has several months to hand down a ruling.
The Franco-German group has spurned Sanofi's bid as "laughable," saying the price offered is far too low.
"They need us, we don't need them," Aventis president Igor Landau said.
He has warned Aventis shareholders that Sanofi, a smaller company currently making strong profits, wants them to bear the burden of "serious uncertainties" surrounding the predator's future prospects and research portfolio.
Sanofi chief executive Jean-Francois Dehecq said the hostile takeover of the bigger company would "speed up the growth of major products, combine marketing and commercial forces and maximize the launch of the two groups' products."
On Monday, Sanofi refused to sweeten its bid, but tried to woo Aventis shareholders by flexing its financial strength.
Sanofi posted a 17.7 percent increase in net profit to 2.076 billion euros last year from 1.759 billion euros, beating analysts' forecasts that ranged from 2.025 billion euros to 2.033 billion euros.
Analysts had forecast that Sanofi would unveil glowing results and dazzling prospects for future growth.
Looking ahead, Sanofi said it expected sales growth this year to match last year's 8.1 percent despite the unfavorable impact of currency fluctuations.
Turning to its products, Sanofi said it recorded "very positive results" from clinical trials of its anti-smoking and anti-obesity drug Rimonabant, heart treatment Dronedarone and sleep drug Ambien.
On Monday Sanofi-Synthelabo shares dipped 0.09 percent to 55.30 euros while Aventis rose 1.22 percent to 62.15 on a Paris market that closed with a gain of 0.79 percent.
SECURITY: As China is ‘reshaping’ Hong Kong’s population, Taiwan must raise the eligibility threshold for applications from Hong Kongers, Chiu Chui-cheng said When Hong Kong and Macau citizens apply for residency in Taiwan, it would be under a new category that includes a “national security observation period,” Mainland Affairs Council (MAC) Minister Chiu Chui-cheng (邱垂正) said yesterday. President William Lai (賴清德) on March 13 announced 17 strategies to counter China’s aggression toward Taiwan, including incorporating national security considerations into the review process for residency applications from Hong Kong and Macau citizens. The situation in Hong Kong is constantly changing, Chiu said to media yesterday on the sidelines of the Taipei Technology Run hosted by the Taipei Neihu Technology Park Development Association. With
CARROT AND STICK: While unrelenting in its military threats, China attracted nearly 40,000 Taiwanese to over 400 business events last year Nearly 40,000 Taiwanese last year joined industry events in China, such as conferences and trade fairs, supported by the Chinese government, a study showed yesterday, as Beijing ramps up a charm offensive toward Taipei alongside military pressure. China has long taken a carrot-and-stick approach to Taiwan, threatening it with the prospect of military action while reaching out to those it believes are amenable to Beijing’s point of view. Taiwanese security officials are wary of what they see as Beijing’s influence campaigns to sway public opinion after Taipei and Beijing gradually resumed travel links halted by the COVID-19 pandemic, but the scale of
A US Marine Corps regiment equipped with Naval Strike Missiles (NSM) is set to participate in the upcoming Balikatan 25 exercise in the Luzon Strait, marking the system’s first-ever deployment in the Philippines. US and Philippine officials have separately confirmed that the Navy Marine Expeditionary Ship Interdiction System (NMESIS) — the mobile launch platform for the Naval Strike Missile — would take part in the joint exercise. The missiles are being deployed to “a strategic first island chain chokepoint” in the waters between Taiwan proper and the Philippines, US-based Naval News reported. “The Luzon Strait and Bashi Channel represent a critical access
Pope Francis is be laid to rest on Saturday after lying in state for three days in St Peter’s Basilica, where the faithful are expected to flock to pay their respects to history’s first Latin American pontiff. The cardinals met yesterday in the Vatican’s synod hall to chart the next steps before a conclave begins to choose Francis’ successor, as condolences poured in from around the world. According to current norms, the conclave must begin between May 5 and 10. The cardinals set the funeral for Saturday at 10am in St Peter’s Square, to be celebrated by the dean of the College
RSS